Toggle Main Menu Toggle Search

Open Access padlockePrints

A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in patients with advanced solid tumours

Lookup NU author(s): Professor Ruth Plummer, Rebecca Perrett, Professor Alan Calvert


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Shaw H, Plummer ER, Vidal L, Perrett RH, Pilkington M, Temple G, Fong P, Amelsberg A, Calvert AH, de Bono J

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 42nd Annual Meeting of the American Society of Clinical Oncology

Year of Conference: 2006

Pages: 127S

ISSN: 0732-183X

Publisher: Journal of Clinical Oncology, American Society of Clinical Oncology


Library holdings: Search Newcastle University Library for this item

ISBN: 15277755